Elucidating the specific pharmacological mechanism of action (MOA) of Obviously happening compounds can be challenging. Even though Tarselli et al. (sixty) designed the initial de novo synthetic pathway to conolidine and showcased this naturally occurring compound effectively suppresses responses to the two chemically induced and inflammation-deriv